Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | SMARCA4 |
Variant | R1413Qfs*41 |
Impact List | frameshift |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | SMARCA4 R1413Qfs*41 indicates a shift in the reading frame starting at amino acid 1413 and terminating 41 residues downstream causing a premature truncation of the 1647 amino acid Smarca4 protein (UniProt.org). Due to the loss of the Bromo domain (UniProt.org), R1413Qfs*41 is predicted to lead to a loss of Smarca4 protein function. |
Associated Drug Resistance | |
Category Variants Paths |
SMARCA4 mutant SMARCA4 inact mut SMARCA4 R1413Qfs*41 |
Transcript | NM_003072.5 |
gDNA | chr19:g.11041374_11041375delGC |
cDNA | c.4238_4239delGC |
Protein | p.R1413Qfs*41 |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_017027163 | chr19:g.11041374_11041375delGC | c.4238_4239delGC | p.R1413Qfs*41 | RefSeq | GRCh38/hg38 |
NM_001128845.1 | chr19:g.(11041463_11058282) | c.(4237_4362) | p.R1413Qfs*41 | RefSeq | GRCh38/hg38 |
NM_001128846.2 | chr19:g.(11041463_11058285) | c.(4237_4362) | p.R1413Qfs*41 | RefSeq | GRCh38/hg38 |
NM_003072.5 | chr19:g.11041374_11041375delGC | c.4238_4239delGC | p.R1413Qfs*41 | RefSeq | GRCh38/hg38 |
NM_001128845.2 | chr19:g.(11041463_11058282) | c.(4237_4362) | p.R1413Qfs*41 | RefSeq | GRCh38/hg38 |
NM_001128845 | chr19:g.(11041463_11058282) | c.(4237_4362) | p.R1413Qfs*41 | RefSeq | GRCh38/hg38 |
XM_024451664.1 | chr19:g.(11041463_11058282) | c.(4237_4362) | p.R1413Qfs*41 | RefSeq | GRCh38/hg38 |
NM_001128846 | chr19:g.(11041463_11058285) | c.(4237_4362) | p.R1413Qfs*41 | RefSeq | GRCh38/hg38 |
NM_001128844.1 | chr19:g.11041374_11041375delGC | c.4238_4239delGC | p.R1413Qfs*41 | RefSeq | GRCh38/hg38 |
NM_003072 | chr19:g.11041374_11041375delGC | c.4238_4239delGC | p.R1413Qfs*41 | RefSeq | GRCh38/hg38 |
XM_024451665.1 | chr19:g.(11041463_11058285) | c.(4237_4362) | p.R1413Qfs*41 | RefSeq | GRCh38/hg38 |
NM_001128844.3 | chr19:g.11041374_11041375delGC | c.4238_4239delGC | p.R1413Qfs*41 | RefSeq | GRCh38/hg38 |
NM_001128844 | chr19:g.11041374_11041375delGC | c.4238_4239delGC | p.R1413Qfs*41 | RefSeq | GRCh38/hg38 |
XM_017027165 | chr19:g.(11041463_11058282) | c.(4237_4362) | p.R1413Qfs*41 | RefSeq | GRCh38/hg38 |
XM_017027166 | chr19:g.(11041463_11058285) | c.(4237_4362) | p.R1413Qfs*41 | RefSeq | GRCh38/hg38 |
XM_024451662.1 | chr19:g.11041374_11041375delGC | c.4238_4239delGC | p.R1413Qfs*41 | RefSeq | GRCh38/hg38 |
NM_001128846.1 | chr19:g.(11041463_11058285) | c.(4237_4362) | p.R1413Qfs*41 | RefSeq | GRCh38/hg38 |
NM_003072.3 | chr19:g.11041374_11041375delGC | c.4238_4239delGC | p.R1413Qfs*41 | RefSeq | GRCh38/hg38 |
XM_047439244.1 | chr19:g.11041374_11041375delGC | c.4238_4239delGC | p.R1413Qfs*41 | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|